Insulin aspart, recombinant Subcutaneous and Zylet ophthalmic
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Zylet ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Zylet
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Zyloprim
- Insulin aspart, recombinant Subcutaneous-Zymine Liquid
- Insulin aspart, recombinant Subcutaneous-Zymine-D
- Insulin aspart, recombinant Subcutaneous-Zyncof
- Insulin aspart, recombinant Subcutaneous-Zypitamag
- Insulin aspart, recombinant Subcutaneous-Zypram Cream
- Zylet ophthalmic-Insulin degludec
- Zylet ophthalmic-Insulin Degludec (U-100) Prefilled Pens
- Zylet ophthalmic-Insulin Degludec (U-100) Vials
- Zylet ophthalmic-Insulin Degludec (U-200) Prefilled Pens
- Zylet ophthalmic-Insulin degludec and liraglutide
- Zylet ophthalmic-Insulin degludec and liraglutide Subcutaneous